FGF23 and chronic kidney disease: The increased production of fibroblast growth factor-23 [32,33], αKlotho [34,35], and calcitriol [36] deficiencies are major candidate non-hemodynamic factors of cardiomyopathy progression in patients with CKD [37,38,39,40].